{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:37:57Z","timestamp":1780414677929,"version":"3.54.1"},"reference-count":71,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Background: Chronic pulmonary diseases are characterized by airway remodeling due to complex multicellular responses and the production of free oxygen radicals. They lead to a progressive decline of pulmonary functions. Adelmidrol is an analogue of palmitoylethanolamide (PEA), which is a well-known anti-inflammatory and anti-oxidant compound. In this study, we investigated the efficacy of adelmidrol (10 mg\/Kg) for bleomycin-induced pulmonary fibrosis in mice. Methods: Bleomycin intratracheal administration was performed on the first day and for the following twenty-one days, mice were treated with adelmidrol (10 mg\/Kg). Results: The survival rate and body weight gain were recorded daily. At the end of the experiment, adelmidrol-administered animals showed reduced airway infiltration by inflammatory cells, Myeloperoxidase (MPO) activity, and pro-inflammatory cytokine overexpression (IL,6 IL-1\u03b2, TNF-\u03b1, and TGF-1\u03b2). Moreover, adelmidrol treatment was able to manage the significant incapacity of antioxidants and elevation of the oxidant burden, as shown by the MDA, SOD, and GSH levels and decreased nitric oxide production. It was also able to significantly modulate the JAK2\/STAT3 and I\u03baB\u03b1\/NF-kB pathway. Histologic examination of the lung tissues showed reduced sample injury, mast cell degranulation, chymase activity, and collagen deposition. Conclusions: In sum, our results propose adelmidrol as a therapeutic approach in the treatment of pulmonary fibrosis.<\/jats:p>","DOI":"10.3390\/antiox9070601","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T09:25:28Z","timestamp":1594373128000},"page":"601","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Adelmidrol: A New Promising Antioxidant and Anti-Inflammatory Therapeutic Tool in Pulmonary Fibrosis"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0223-1403","authenticated-orcid":false,"given":"Roberta","family":"Fusco","sequence":"first","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-0043","authenticated-orcid":false,"given":"Marika","family":"Cordaro","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Dental and Morphological and Functional Imaging University of Messina, Via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Genovese","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9492-3161","authenticated-orcid":false,"given":"Daniela","family":"Impellizzeri","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-2505","authenticated-orcid":false,"given":"Rosalba","family":"Siracusa","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6840-3154","authenticated-orcid":false,"given":"Enrico","family":"Gugliandolo","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8545-990X","authenticated-orcid":false,"given":"Alessio Filippo","family":"Peritore","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0389-3871","authenticated-orcid":false,"given":"Ramona","family":"D\u2019Amico","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7629-3132","authenticated-orcid":false,"given":"Rosalia","family":"Crupi","sequence":"additional","affiliation":[{"name":"Department of Veterinary Sciences, University of Messina, 98168 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6131-3690","authenticated-orcid":false,"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy"},{"name":"Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, Saint Louis, MO 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6725-8581","authenticated-orcid":false,"given":"Rosanna","family":"Di Paola","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1476-5381.2011.01247.x","article-title":"Novel therapeutic approaches for pulmonary fibrosis","volume":"163","author":"Datta","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1440-1827.1995.tb03503.x","article-title":"Evolution of three patterns of intra-alveolar fibrosis produced by bleomycin in rats","volume":"45","author":"Usuki","year":"1995","journal-title":"Pathol. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.resp.2013.09.011","article-title":"Pathogenesis pathways of idiopathic pulmonary fibrosis in bleomycin-induced lung injury model in mice","volume":"190","author":"Shi","year":"2014","journal-title":"Respir. Physiol. Neurobiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.200505-717OC","article-title":"Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model","volume":"173","author":"Chaudhary","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","article-title":"The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?","volume":"40","author":"Moeller","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1054\/plef.2001.0348","article-title":"Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: Metabolism and function","volume":"66","author":"Schmid","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.phrs.2016.07.010","article-title":"Ultramicronized palmitoylethanolamide (PEA-um((R))) in the treatment of idiopathic pulmonary fibrosis","volume":"111","author":"Impellizzeri","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Fusco, R., Gugliandolo, E., Campolo, M., Evangelista, M., Di Paola, R., and Cuzzocrea, S. (2017). Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178553"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/SHK.0000000000000578","article-title":"Protective Effects of Ultramicronized Palmitoylethanolamide (PEA-um) in Myocardial Ischaemia and Reperfusion Injury in VIVO","volume":"46","author":"Cordaro","year":"2016","journal-title":"Shock"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"11364","DOI":"10.1096\/fj.201900538R","article-title":"The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice","volume":"33","author":"Impellizzeri","year":"2019","journal-title":"FASEB J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.toxlet.2015.10.006","article-title":"A novel protective formulation of Palmitoylethanolamide in experimental model of contrast agent induced nephropathy","volume":"240","author":"Cordaro","year":"2016","journal-title":"Toxicol. Lett."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12974-014-0136-0","article-title":"Micronized\/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain","volume":"11","author":"Impellizzeri","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tvjl.2015.10.060","article-title":"Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis","volume":"207","author":"Petrosino","year":"2016","journal-title":"Vet. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.phrs.2018.05.013","article-title":"Urology Study, G. Adelmidrol + sodium hyaluronate in IC\/BPS or conditions associated to chronic urothelial inflammation. A translational study","volume":"134","author":"Ostardo","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1582-4934.2008.00353.x","article-title":"Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats","volume":"13","author":"Cinelli","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s13075-016-1189-5","article-title":"Adelmidrol, in combination with hyaluronic acid, displays increased anti-inflammatory and analgesic effects against monosodium iodoacetate-induced osteoarthritis in rats","volume":"18","author":"Fusco","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/mol.116.105668","article-title":"Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease","volume":"90","author":"Cordaro","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/jpet.108.136903","article-title":"Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury","volume":"326","author":"Genovese","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1017\/S0007114515002597","article-title":"Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice","volume":"114","author":"Impellizzeri","year":"2015","journal-title":"Br. J. Nutr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12931-019-1054-6","article-title":"Aminoguanidine affects systemic and lung inflammation induced by lipopolysaccharide in rats","volume":"20","author":"Saadat","year":"2019","journal-title":"Respir. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/thoraxjnl-2018-211516","article-title":"Mechanical stress-induced mast cell degranulation activates TGF-\u03b21 signalling pathway in pulmonary fibrosis","volume":"74","author":"Shimbori","year":"2019","journal-title":"Thorax"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"21515","DOI":"10.1038\/srep21515","article-title":"Suhuang antitussive capsule at lower doses attenuates airway hyperresponsiveness, inflammation, and remodeling in a murine model of chronic asthma","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_24","first-page":"285","article-title":"Proteolytic enzyme activities in rat peritoneal exudate","volume":"42","author":"Pasztor","year":"1991","journal-title":"Acta Biol. Hung."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejphar.2003.08.050","article-title":"Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in mice","volume":"478","author":"Tomimori","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0160-5402(85)90029-4","article-title":"Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium","volume":"14","author":"Mullane","year":"1985","journal-title":"J. Pharmacol. Methods"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"33841","DOI":"10.18632\/oncotarget.8409","article-title":"Preventive and therapeutic effects of thymosin beta4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis","volume":"7","author":"Conte","year":"2016","journal-title":"Oncotarget"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7967868","DOI":"10.1155\/2018\/7967868","article-title":"Serotonin Exhibits Accelerated Bleomycin-Induced Pulmonary Fibrosis through TPH1 Knockout Mouse Experiments","volume":"2018","author":"Zhang","year":"2018","journal-title":"Mediators Inflamm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1164\/ajrccm.163.7.9911068","article-title":"Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse","volume":"163","author":"Yasui","year":"2001","journal-title":"Am. J. Resp. Crit. Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/thx.2003.008979","article-title":"Attenuation of bleomycin induced pulmonary fibrosis in mice using the heme oxygenase inhibitor Zn-deuteroporphyrin IX-2, 4-bisethylene glycol","volume":"59","author":"Atzori","year":"2004","journal-title":"Thorax"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fphys.2017.00193","article-title":"Prevention of Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice by Paeonol","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1124\/jpet.115.224675","article-title":"Pharmacological In Vivo Inhibition of S-Nitrosoglutathione Reductase Attenuates Bleomycin-Induced Inflammation and Fibrosis","volume":"355","author":"Luzina","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_33","first-page":"815","article-title":"Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-\u03b2\/Smad signaling pathway","volume":"29","author":"Liu","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.phrs.2017.06.014","article-title":"Palmitoylethanolamide and Polydatin combination reduces inflammation and oxidative stress in vascular injury","volume":"123","author":"Gugliandolo","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"C145","DOI":"10.1007\/BF01972748","article-title":"A proposed autacoid mechanism controlling mastocyte behaviour","volume":"39","author":"Aloe","year":"1993","journal-title":"Agents Actions"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.pain.2008.06.003","article-title":"The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: Involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors","volume":"139","author":"Costa","year":"2008","journal-title":"Pain"},{"key":"ref_38","first-page":"3","article-title":"Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats","volume":"7","author":"Luongo","year":"2011","journal-title":"Mol. Pain"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.bbi.2011.02.006","article-title":"Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury","volume":"25","author":"Esposito","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0041-008X(89)90294-9","article-title":"Alteration of bronchoalveolar lavage cell populations following bleomycin treatment in mice","volume":"100","author":"Ranges","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3s","DOI":"10.1183\/09031936.01.00266001","article-title":"Cytokines and the lung","volume":"34","author":"Toews","year":"2001","journal-title":"Eur. Respir. J. Suppl."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1753465810379801","article-title":"The pathogenesis of idiopathic pulmonary fibrosis","volume":"4","author":"Coward","year":"2010","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02034932","article-title":"Mechanisms of bleomycin-induced lung damage","volume":"65","author":"Hay","year":"1991","journal-title":"Arch. Toxicol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/ars.2007.1916","article-title":"Antioxidants as potential therapeutics for lung fibrosis","volume":"10","author":"Day","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/ars.2007.1908","article-title":"Extracellular superoxide dismutase in pulmonary fibrosis","volume":"10","author":"Gao","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1016\/0006-2952(86)90776-8","article-title":"Protection against paraquat-induced injury by exogenous GSH in pulmonary alveolar type II cells","volume":"35","author":"Hagen","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1021\/cr030117g","article-title":"Antitumor antibiotics: Bleomycin, enediynes, and mitomycin","volume":"105","author":"Galm","year":"2005","journal-title":"Chem. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.bbadis.2012.11.021","article-title":"Oxidative stress and pulmonary fibrosis","volume":"1832","author":"Cheresh","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1177\/039463201002300408","article-title":"GW0742, a high affinity PPAR-beta\/delta agonist reduces lung inflammation induced by bleomycin instillation in mice","volume":"23","author":"Galuppo","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1465-9921-12-41","article-title":"Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis","volume":"12","author":"Talero","year":"2011","journal-title":"Respir. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00210-011-0637-7","article-title":"MEK inhibition suppresses the development of lung fibrosis in the bleomycin model","volume":"384","author":"Galuppo","year":"2011","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1309\/W7T9-HW9V-V94B-R9KM","article-title":"Inducible nitric oxide synthase, but not xanthine oxidase, is highly expressed in interstitial pneumonias and granulomatous diseases of human lung","volume":"117","author":"Lakari","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bcp.2005.12.017","article-title":"JAK\/STAT signal transduction: Regulators and implication in hematological malignancies","volume":"71","author":"Valentino","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/annrheumdis-2013-204256","article-title":"Inhibition of casein kinase II reduces TGFbeta induced fibroblast activation and ameliorates experimental fibrosis","volume":"74","author":"Zhang","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1165\/rcmb.2016-0259OC","article-title":"NF-\u03baB mediates mesenchymal transition, remodeling, and pulmonary fibrosis in response to chronic inflammation by viral RNA patterns","volume":"56","author":"Tian","year":"2017","journal-title":"Am. J. Resp. Cell Mol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0006-2952(99)00296-8","article-title":"Oxidative stress and nuclear factor-kappaB activation: A reassessment of the evidence in the light of recent discoveries","volume":"59","author":"Bowie","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-134-2-200101160-00015","article-title":"Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy","volume":"134","author":"Selman","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/mi.2009.136","article-title":"Advances in mast cell biology: New understanding of heterogeneity and function","volume":"3","author":"Moon","year":"2010","journal-title":"Mucosal. Immunol."},{"key":"ref_59","first-page":"2037","article-title":"Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders","volume":"149","author":"Inoue","year":"1996","journal-title":"Am. J. Pathol."},{"key":"ref_60","first-page":"717","article-title":"Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders","volume":"40","author":"Kawanami","year":"1979","journal-title":"Lab. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2559.2012.04197.x","article-title":"Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis","volume":"61","author":"Cha","year":"2012","journal-title":"Histopathology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1465-9921-12-139","article-title":"Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis","volume":"12","author":"Andersson","year":"2011","journal-title":"Respir. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/path.1780","article-title":"c-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases","volume":"206","author":"Edwards","year":"2005","journal-title":"J. Pathol."},{"key":"ref_64","first-page":"174","article-title":"Are mast cells instrumental for fibrotic diseases?","volume":"4","author":"Rapley","year":"2013","journal-title":"Front. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11010-007-9676-2","article-title":"Chymase induces profibrotic response via transforming growth factor-beta 1\/Smad activation in rat cardiac fibroblasts","volume":"310","author":"Zhao","year":"2008","journal-title":"Mol. Cell Biochem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1096\/fj.00-0273com","article-title":"Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: A novel function for chymase","volume":"15","author":"Lindstedt","year":"2001","journal-title":"FASEB J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1513\/pats.201203-023AW","article-title":"The impact of TGF-\u03b2 on lung fibrosis: From targeting to biomarkers","volume":"9","author":"Fernandez","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI119590","article-title":"Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung","volume":"100","author":"Sime","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"L348","DOI":"10.1152\/ajplung.00289.2009","article-title":"Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis","volume":"298","author":"Tanaka","year":"2010","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: Regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1513\/pats.201201-003AW","article-title":"TGF-beta activation and lung fibrosis","volume":"9","author":"Tatler","year":"2012","journal-title":"Proc. Am. Thorac. Soc."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/9\/7\/601\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:49:36Z","timestamp":1760176176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/9\/7\/601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":71,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["antiox9070601"],"URL":"https:\/\/doi.org\/10.3390\/antiox9070601","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]}}}